SSS 2024
Chair: Caitlin Jones
Treatment effect modifiers for return-to-work in patients with musculoskeletal disorders (#17)
2:30 PM
Changes in pregabalin dispensing to Australians with workers’ compensation claims for low back pain following the listing of pregabalin on the pharmaceutical benefits scheme (#18)
2:33 PM
Antidepressants for non-specific low back pain and spine-related leg pain: A Cochrane review (#19)
2:36 PM
Influence of workers’ compensation on outcomes in spinal endoscopic surgery. (#20)
2:39 PM
RESHAP-ED: a randomised trial of primary-contact physiotherapy for musculoskeletal pain in emergency departments (#21)
2:42 PM
Efficacy and harms of non-steroidal anti-inflammatory drugs (NSAIDs) and opioids for musculoskeletal pain in older persons (#22)
2:45 PM